Financial News

Date Title and Summary Additional Formats
Toggle Summary Leading Medical Physics Meeting to Feature More than 50 Presentations on ViewRay's MRIdian MRI-Guided Radiotherapy
Presentations Highlight MRIdian Clinical Experience with On-Table Adaptive Therapy Combined with the Novel Ability to Visualize and Actively Target Tumors that Move CLEVELAND , July 26, 2018 /PRNewswire/ -- ViewRay, Inc. (Nasdaq: VRAY), makers of the world's only FDA -cleared MRI-guided radiation
Toggle Summary ViewRay Appoints Scott Drake as President, Chief Executive Officer and a Member of the Board of Directors, Shar Matin as Chief Operating Officer, and D. Keith Grossman as a Member of the Board of Directors
New Officers and Directors Bring Extensive Medical Company Growth Experience to ViewRay ViewRay Pre-Releases Preliminary Second Quarter 2018 Revenue of $16 Million and Reaffirms Revenue Guidance of $80 to $90 Million for 2018 CLEVELAND , July 24, 2018 /PRNewswire/ --  ViewRay, Inc.
Toggle Summary ViewRay's MRIdian Linac Awarded French Tender for MR Image-guided Radiation Therapy
UNICANCER to Bring Next Generation Radiotherapy to Centre Georges-François Leclerc (CGFL) CLEVELAND , July 11, 2018   /PRNewswire/ --  ViewRay, Inc. (Nasdaq: VRAY) announced that the company's MRIdian® Linac has been selected for installation at Centre Georges-François Leclerc (CGFL) in Dijon,
Toggle Summary Loyola Medicine/Palos Health Installs ViewRay's MRIdian Linac System for MR Image-Guided Radiation Therapy
Chicago-Area Provider Becomes First Community Hospital in the U.S. with ViewRay's Next Generation Linear Accelerator-Based System CLEVELAND , July 9, 2018 /PRNewswire/ --  ViewRay, Inc. (Nasdaq: VRAY) announced today that Palos Health , in partnership with Loyola Medicine, has installed ViewRay's
Toggle Summary University of Wisconsin Begins Patient Treatments with ViewRay's MRIdian Linac
Becomes the First Hospital to Upgrade Previous Generation MRIdian to Advanced Linear Accelerator-based System CLEVELAND , June 21, 2018 /PRNewswire/   -- ViewRay, Inc. (Nasdaq: VRAY) announced today that University of Wisconsin Carbone Cancer Center in Madison, Wisconsin , has begun patient
Toggle Summary Pioneer of MR Image-Guided Radiotherapy, Washington University, Begins First Clinical Treatments with its Second ViewRay MRIdian System
Next Generation Cancer Therapy Enables Delivery of Higher, Potentially More Effective Radiation Dose Regimens CLEVELAND , June 13, 2018 /PRNewswire/ -- ViewRay, Inc. (Nasdaq: VRAY) announced today that the Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine
Toggle Summary ViewRay® to Present at the Jefferies 2018 Global Healthcare Conference
CLEVELAND , June 4, 2018 /PRNewswire/ --  ViewRay, Inc. (NASDAQ: VRAY) announced today that James F. Dempsey , PhD, Founder and Chief Scientific Officer, and Ajay Bansal , Chief Financial Officer, are scheduled to present at the Jefferies 2018 Global Healthcare Conference in New York, NY .
Toggle Summary World-Leading Oncologists to Meet in Miami for Adaptive MR Image-Guided Radiotherapy Symposium
Educational Event Aims to Share Clinical Expertise and Best Practices in MR Image-guided Radiation Therapy CLEVELAND , May 23, 2018 /PRNewswire/ -- Experts in MR image-guided radiation therapy will share their experiences during an educational symposium to be held on Friday, September 28, 2018 in
Toggle Summary ViewRay to Present at the UBS Global Healthcare Conference
CLEVELAND , May 16, 2018 /PRNewswire/ -- ViewRay ® , Inc. (NASDAQ: VRAY) announced today that Chris Raanes , Chief Executive Officer, and Ajay Bansal , Chief Financial Officer, are scheduled to present at the UBS Global Healthcare Conference in New York, NY . Event :                 UBS Global
Toggle Summary ViewRay Reports First Quarter 2018 Financial Results
Reiterates 2018 Financial Guidance CLEVELAND , May 10, 2018 /PRNewswire/ --  ViewRay, Inc. (Nasdaq: VRAY) today announced financial results for the first quarter ended March 31, 2018 . First Quarter 2018 Highlights: Total revenue of $26.2 million, primarily from 4 revenue units, up from $1.2
Toggle Summary ViewRay Announces Conference Call and Webcast of First Quarter 2018 Financial Results to be Held After Market on May 10, 2018
CLEVELAND , May 7, 2018 /PRNewswire/ --  ViewRay, Inc. (Nasdaq: VRAY) announced today details relating to the release of its first quarter 2018 financial results, which will take place on Thursday, May 10, 2018 after market. ViewRay will hold a conference call on Thursday, May 10, 2018 at 4:30 p.m.
Toggle Summary ViewRay's Clinical Cooperative Think Tank Convenes to Discuss Clinical Experience and Further Trial Development for MRIdian MR-Image Guided Radiotherapy
MRIdian On-Table Adaptive Therapy a Focal Point at the European Society for Radiotherapy and Oncology (ESTRO) Annual Meeting CLEVELAND , May 2, 2018 /PRNewswire/ -- ViewRay, Inc. (Nasdaq: VRAY) announced today that members of its Clinical Cooperative Think Tank (C2T2) gathered last week in
Toggle Summary Miami Cancer Institute at Baptist Health South Florida Becomes Second Institution in the United States to Treat Patients with ViewRay's MRIdian® Linac
Novel MR Image-Guided Radiotherapy Enables High-Definition Tumor Visualization and On-table Adaptive Cancer Treatment CLEVELAND , April 30, 2018 /PRNewswire/ --  ViewRay, Inc. (Nasdaq: VRAY) announced today that Miami Cancer Institute at Baptist Health South Florida has begun patient treatments
Toggle Summary VU University Medical Center in Amsterdam Delivers First Ever Linear Accelerator-Based On-Table Adaptive MR Image-Guided Radiotherapy Treatment on ViewRay MRIdian® Linac
Two Prestigious Centers in Europe Start Treating Patients with MRIdian® Linac CLEVELAND , April 19, 2018   /PRNewswire/ -- ViewRay, Inc. (Nasdaq: VRAY) announced today that VU University Medical Center (VUmc) in Amsterdam has begun patient treatments using the Company's next generation system,
Toggle Summary ViewRay Unveils New Soft Tissue Visualization Technologies to Further Advance MR Image-Guided Radiotherapy
New MR Pulse Sequences and Imaging Enhancements Expected to Provide Cutting-Edge Tumor and Healthy Tissue Visualization* CLEVELAND , April 18, 2018 /PRNewswire/ -- ViewRay, Inc. (Nasdaq: VRAY) announced today new MR imaging technologies under development for its MRIdian ® Linac radiotherapy system.
Toggle Summary University Clinic Heidelberg Completes Installation and Commissioning of ViewRay's MRIdian MR Image-Guided Radiotherapy Linac
MR-Image Guided Linac Treatments in Europe to Commence by Mid-April CLEVELAND , April 4, 2018 /PRNewswire/ -- ViewRay, Inc. (Nasdaq: VRAY) announced today that the University Clinic Heidelberg in Germany has completed installation and commissioning of the hospital's new MRIdian Linac, the
Toggle Summary ViewRay Surpasses 50th Order for MRIdian® System for Precision Cancer Treatment
Milestone Demonstrates Rapid Adoption of Next-Generation MR-Image Guided Radiation Therapy CLEVELAND , March 27, 2018 /PRNewswire/ -- ViewRay, Inc. (Nasdaq: VRAY) announced that the company surpassed its 50 th MRIdian MR image-guided radiation therapy system order during the first quarter of 2018 -
Toggle Summary Nearly 200 Oncology Experts Gather to Discuss Advanced Applications of MR Image-Guided Radiotherapy
Educational Event Featured Presentations from Five MRIdian® Users Highlighting MR Image-guided Radiation Therapy Clinical Experience and Best Practices CLEVELAND , March 16, 2018 /PRNewswire/ -- Experts in MR image-guided radiation therapy convened today to discuss MR image-guided radiation therapy
Toggle Summary ViewRay's MRIdian MR Image-Guided Radiotherapy Linac Receives Japanese Regulatory Approval (Shonin)
Clearance Expected to Accelerate Market Adoption of Next-Generation Cancer Care CLEVELAND , March 15, 2018 /PRNewswire/ -- ViewRay, Inc. (Nasdaq: VRAY) announced today that the company received Shonin approval from the Japanese Ministry of Health, Labor and Welfare (MHLW) to market the MRIdian
Toggle Summary ViewRay Finalizes Order for MR Image-Guided Radiation Therapy System at University Hospital Zurich
Oncologists at Leading Swiss Hospital Select MRIdian Linac as Preferred Technology In Competitive European Tender CLEVELAND , March 14, 2018 /PRNewswire/ --  ViewRay, Inc. (Nasdaq: VRAY) announced today an order for the company's MRIdian® MR image-guided linac at the University Hospital Zurich

Stock Quote

Copyright West LLC. Minimum 15 minutes delayed.

Financial Events
More events are coming soon.
Featured Items

E-mail Alerts

Alerts are e-mailed to you whenever certain new company information is posted to this site. Sign-up Now!
Click here for E-mail Alerts

Transfer Agent
American Stock Transfer & Trust Company, LLC
6201 15th Avenue
Brooklyn, NY 11219
(800) 937-5449
Website: www.amstock.com
Email: info@amstock.com

In Need of Customer Support? Contact

  Language Select